Meningococcal ACIP Vaccine Recommendations
Advisory Committee for Immunization Practices (ACIP)
On this Page
![MMWR image](https://webarchive.library.unt.edu/web/20161211185518im_/http://www.cdc.gov/vaccines/hcp/acip-recs/images/mmwr-blue-logo.gif)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Meningococcal Vaccine Recommendations
- MMWR, November 4, 2016, Vol 65 #43
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016
Print version [6 pages] - MMWR, October 23, 2015, Vol 64 #41
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
Print version [24 pages] - MMWR, June 12, 2015, Vol 64 #22
Use of Serogroup B Meningococcal (MenB) Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
Print version [16 pages] - MMWR, June 20, 2014, Vol 63 #24
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk, 2013
Print version [16 pages] - MMWR, March 22, 2013, Vol 62, #RR02
Prevention and Control of Meningococcal Disease
Print version [32 pages] - See also:
ARCHIVED Historical Meningococcal Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, January 25, 2013, Vol 62, #3
Infant Meningococcal Vaccination: ACIP Recommendations and Rationale
Print version [32 pages] - MMWR, October 14, 2011, Vol 60, #40
Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Print version [2.03MB, 36 pages]
- MMWR, August 5, 2011, Vol 60, #30
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease -- ACIP, 2011
Print version [1.12MB, 36 pages] - MMWR, January 28, 2011, Vol 60, #03
Updated Recommendations for Use of Meningococcal Conjugate Vaccines -- ACIP, 2010
Print version [28 pages] - MMWR, March 12, 2010, Vol 59, #09
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use -- ACIP, 2010
Print version [20 pages] - MMWR, September 25, 2009, Vol 58, #37
Updated Recommendation from the ACIP for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
Print version [1.49MB, 32 pages] - MMWR, May 2, 2008, Vol 57, #17
Report from ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Print version [28 pages] - MMWR, December 7, 2007, Vol 56, #48
Notice to Readers: Recommendation from ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease
Print version [24 pages] - MMWR, August 10, 2007, Vol 56, #31
Notice to Readers: Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine
Print version [28 pages] - MMWR, November 3, 2006, Vol 55, #43
Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 Years
Print version [23 pages] - MMWR, September 22, 2006, Vol 55, #37
Inadvertent Misadministration of Meningococcal Conjugate Vaccine -- United States, June-August 2005
Print version [24 pages] - MMWR, May 26, 2006, Vol 55, #20
Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 Years
Print version [32 pages] - MMWR, May 27, 2005, Vol 54, #RR-07
Prevention and Control of Meningococcal Disease
Print version [28 pages] - MMWR, Feb 14, 1997, Vol 46, #RR-5
Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIP
(PDF not available)
- Page last reviewed: October 22, 2015
- Page last updated: November 4, 2016
- Content source: